AUSTIN, Texas, Aug. 13, 2015 (GLOBE NEWSWIRE) -- LDR Holding Corporation (NASDAQ:LDRH) ("LDR" or the "Company"), a global medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies, today announced the pricing of its public offering of 2,000,000 shares of its common stock at a price to the public of $40.00 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to 300,000 additional shares of its common stock.
Piper Jaffray and William Blair are acting as joint book-running managers for the offering. Cowen and Company and RBC Capital Markets are acting as co-lead managers. BMO Capital Markets, JMP Securities, Stephens Inc. and Brean Capital are acting as co-managers.
This offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-199882) that was initially filed with the U.S. Securities and Exchange Commission (the "SEC") on November 5, 2014. A preliminary prospectus supplement describing the terms of the offering has been filed with the SEC and forms a part of the effective registration statement. Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the offering, and when available, copies of the final prospectus supplement and accompanying prospectus relating to the offering may be obtained from the offices of Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402 or by telephone at 800-747-3924 or by email at email@example.com William Blair & Company, L.L.C. at 222 West Adams Street, Chicago, IL 60606, Attention: Prospectus Department, by telephone at 800-621-0687, or by email at firstname.lastname@example.org.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About LDR Holding Corporation
LDR Holding Corporation is a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders. LDR's primary products are based on its exclusive VerteBRIDGE® fusion and Mobi® non-fusion technology platforms and are designed for applications in the cervical and lumbar spine. These technologies are designed to enable products that are less invasive, provide greater intra-operative flexibility, offer simplified surgical techniques and promote improved clinical outcomes for patients as compared to existing alternatives. In August 2013, LDR received approval from the U.S. Food and Drug Administration (FDA) for the Mobi-C cervical disc replacement device, the first and only cervical disc replacement device to receive FDA approval to treat both one-level and two-level cervical disc disease.
This press release contains statements that constitute forward-looking statements within the meaning of the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief or current expectations of LDR and members of its management team with respect to LDR's future business operations as well as the assumptions upon which such statements are based, and statements pertaining to LDR's expectations regarding the public offering. Actual results could differ materially from those anticipated due to certain risks and uncertainties including, without limitation, risks and uncertainties related to fluctuations in the Company's stock price, changes in market conditions and satisfaction of customary closing conditions related to the public offering. There can be no assurance that LDR will be able to complete the public offering on the anticipated terms, or at all. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found in LDR's Risk Factors disclosure in its Annual Report on Form 10-K, in its Quarterly Reports on Form 10-Q, and in its other filings with the Securities and Exchange Commission as well as the risks identified in the registration statement and the preliminary prospectus supplement relating to the offering. LDR disclaims any responsibility to update any forward-looking statements.
Robert McNamaraExecutive Vice President and Chief Financial OfficerLDR Holding Corporation(512) 344-3333LDR Holding CorporationMatthew Norman Director, Investor Relations(512) 344-3408
Published at Nasdaq GlobeNewswire